Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Wong

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Neurology|October 6, 2004
Headache Caused by Giant Cell ArteritisThomas N Ward, Morris Levin, Robert L Wong
Health and Quality of Life Outcomes|May 24, 2011
Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitisDennis A Revicki, Anne M Rentz, Michelle P Luo, et al.
Rheumatology (Oxford, England)|May 8, 2010
Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasisJürgen Braun, Martin Rudwaleit, Sonja Kary, et al.
Rheumatology (Oxford, England)|January 27, 2010
Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitisMargaret C Reilly, Katherine L Gooch, Robert L Wong, et al.
The Journal of Rheumatology|December 4, 2009
Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitisWalter P Maksymowych, Katherine L Gooch, Robert L Wong, et al.
The Journal of Rheumatology|May 20, 2008
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)Dennis A Revicki, Michelle P Luo, Paul Wordsworth, et al.
Arthritis and Rheumatism|June 26, 2008
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-twoHildrun Haibel, Martin Rudwaleit, Joachim Listing, et al.
Health and Quality of Life Outcomes|February 3, 2009
Psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue subscaleDennis A Revicki, Anne M Rentz, Michelle P Luo, et al.
Arthritis Care & Research|June 11, 2010
Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristicsWalter P Maksymowych, Katherine Gooch, Maxime Dougados, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?Katherine Gooch, David Feeny, Robert L Wong, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Neurology|October 6, 2004
Headache Caused by Giant Cell ArteritisThomas N Ward, Morris Levin, Robert L Wong
Health and Quality of Life Outcomes|May 24, 2011
Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitisDennis A Revicki, Anne M Rentz, Michelle P Luo, et al.
Rheumatology (Oxford, England)|May 8, 2010
Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasisJürgen Braun, Martin Rudwaleit, Sonja Kary, et al.
Rheumatology (Oxford, England)|January 27, 2010
Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitisMargaret C Reilly, Katherine L Gooch, Robert L Wong, et al.
The Journal of Rheumatology|December 4, 2009
Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitisWalter P Maksymowych, Katherine L Gooch, Robert L Wong, et al.
The Journal of Rheumatology|May 20, 2008
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS)Dennis A Revicki, Michelle P Luo, Paul Wordsworth, et al.
Arthritis and Rheumatism|June 26, 2008
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-twoHildrun Haibel, Martin Rudwaleit, Joachim Listing, et al.
Health and Quality of Life Outcomes|February 3, 2009
Psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue subscaleDennis A Revicki, Anne M Rentz, Michelle P Luo, et al.
Arthritis Care & Research|June 11, 2010
Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristicsWalter P Maksymowych, Katherine Gooch, Maxime Dougados, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?Katherine Gooch, David Feeny, Robert L Wong, et al.
Pageof 3